CD4 and cancer: The findings of extensive clinical studies have revealed that immune infiltration, such as CD8+ cytotoxic T-lymphocytes, Th1 and Th17 CD4+ T-cells, and M1 macrophages possess autonomous prognostic value in various cancer types (46–48).